Karman Shares Drop 11.5% as Guidance Raise Was Already Priced In, EPS Miss Sparks Near-Term Re-Rating Risk

The market's verdict on Karman's latest update was a clear "sell the news." Despite the company raising its 2026 revenue guidance to a range of $715 million to $730 million-a figure implying roughly 53% growth-and reporting a record $801 million backlog, shares fell 11.5% on Thursday. This violent reaction points to a classic expectation arbitrage: the positive developments were already priced in, leaving investors to focus on a critical divergence in the numbers.

The core disconnect was in the bottom line. While revenue came in strong at $134.49 million for the quarter, up 47.5% year-over-year, the adjusted earnings per share of $0.11 matched the consensus estimate exactly. In a stock that had already run up 113% this year, that "meet" was a miss against the whisper number. The raised guidance and massive backlog are powerful long-term signals, but they failed to close the immediate expectation gap. Investors were looking for a beat, and they got a print that was merely on target.

This setup created a perfect storm for profit-taking. The stock was trading at a rich P/E ratio of 345.84 after its strong run, making it vulnerable to any hint of disappointment. The lack of an earnings beat, even with a revenue beat, provided that excuse. As one analyst note framed it, the results were "mixed" despite the lifted outlook, a characterization that can accelerate short-term selling even when fundamentals improve. The raised guidance was the bullish case already known; the EPS print was the new, less-than-ideal data point that reset the near-term narrative.

Digging into the Numbers: Quality of the Beat and the Guidance

The headline beat on revenue was real, but the quality of the beat was what mattered. Karman's quarterly revenue of $134.5 million did top the $132.6 million consensus. Yet the critical divergence was in the bottom line, where adjusted earnings per share of 11 cents fell just short of the 12 cents analysts expected. In a stock priced for perfection, that miss overshadowed the top-line strength. It was a classic case of a "good" number being a "bad" surprise because it was below the whisper. The results were, in many ways, as expected as they were disappointing, reinforcing the idea that Karman’s trajectory was already priced in, and the market was waiting for a deviation to act.

Zooming out, the raised guidance paints a steeper growth ramp than the recent past. The company's full-year 2025 adjusted EBITDA grew 37% to $145.3 million. The new 2026 guidance implies a jump to $207 million to $218 million, a range that suggests a 43% to 50% year-over-year increase. This acceleration is the bullish case, but it also sets a high bar. The market is now pricing in a significant step-up in profitability, not just more revenue.

The credibility of this ramp is anchored by the company's massive backlog. With a record quarterly backlog of $801.1 million and a total now exceeding $1 billion, the visibility is strong. However, the growth is concentrated in a few high-demand, high-margin segments. The breakdown shows hypersonics and strategic missile defense revenue up 41.8% and tactical missiles and integrated defense systems revenue soaring 77% year-over-year. This concentration is a double-edged sword. It provides a clear growth story, but it also means the company's trajectory is tightly linked to the continued strength of these specific defense programs.

The bottom line is that the raised guidance is ambitious and supported by a large order book, but it requires flawless execution to hit. The recent quarterly EPS miss shows the company can still fall short of near-term expectations, even when revenue beats. For the stock to re-rate, Karman will need to demonstrate that this guidance ramp is not just a projection, but a trajectory it can consistently meet or exceed.

Valuation and the Guidance Reset: Is the Premium Justified?

The raised guidance sets a high bar, but the stock's valuation already prices in a near-perfect climb. Karman trades at a P/E of roughly 352 after a 248% surge over the past year. That premium is a bet on flawless execution of the ambitious 2026 plan. The recent guidance raise, while bullish, was the expected next step. The market's reaction shows it was already priced in, leaving the stock vulnerable to any stumble in the near-term profit trajectory.

Analyst sentiment remains a key support, with price targets implying significant upside. RBC Capital, for instance, maintains an Outperform rating and a $125 price target, while others see ~40–43% upside from current levels. This bullish consensus is anchored in the company's market exposure and the massive backlog. Yet, the valuation gap between the stock price and a suggested fair value-highlighted by InvestingPro analysis-creates a clear expectation gap. The stock must now deliver on the raised guidance to close that gap and justify the premium.

A potential catalyst for re-rating is the new CEO, Jon Rambeau. His deep defense industry experience, including leading an $8 billion segment at L3Harris, brings credibility to the growth ramp. RBC notes the board does not expect significant strategic changes, which should provide stability. This transition could be a positive signal for execution, but it also raises the bar. The market is now looking for the new leadership to not just meet the raised guidance, but to potentially exceed it, turning the bullish narrative into a reality that the current valuation demands.

Catalysts and Risks: What Moves the Needle Now

The expectation gap is now the central narrative. The stock's 248% surge over the past year priced in a flawless execution of the ambitious 2026 plan. With the guidance raise already in the price, the market's focus has shifted to near-term execution. The catalyst for a recovery will be sequential beats on the raised guidance, proving the company can consistently exceed the new, higher bar.

The primary near-term catalyst is the conversion of the record $801 million quarterly backlog into revenue. The company has expanded its capacity with a new manufacturing hub, which is critical for scaling production. However, the risk is that this ramp-up faces supply chain constraints for specialized materials, a noted negative point in the earnings release. Any delay in converting backlog to sales would directly threaten the 2026 targets and likely trigger a sharp repricing.

A more structural risk is the impact of recent acquisitions. The company's total debt increased to $768 million following the purchase of Seemann and MSC. These acquisitions broaden capabilities but bring a different contract profile, which analysts note could pressure adjusted EBITDA margins in 2026. The market will be watching for the first signs of margin compression or integration costs eating into the raised EBITDA guidance of $207 million to $218 million.

The stock's valuation leaves little room for error. Trading at a P/E of roughly 352 after its massive run, the premium demands perfection. A guidance reset, even a minor one, would be catastrophic for sentiment. The market is now in a "buy the rumor, sell the news" dynamic, where any stumble in the profit trajectory is punished severely. The new CEO, Jon Rambeau, brings deep industry credibility, but his arrival also raises the bar for execution. The board's expectation of no significant strategic changes provides stability, but it does not lower the performance hurdle.

The bottom line is that the needle will be moved by quarterly results that show the company not just hitting the raised guidance, but doing so with healthy margins and without supply chain or integration hiccups. Until then, the stock remains vulnerable to a repricing if the reality of execution falls short of the premium expectations already priced in.